Deal with Mylan to Boost Pfizer’s Generic Lineup in Japan with Definite Impact on Competitors

Pfizer Inc. and Mylan Inc. of the US have signed a collaboration agreement to expand their generic drugs business in Japan. Pfizer’s Established Products business unit currently markets 58 generic drug products with 27 active pharmaceutical ingredients (APIs) in Japan,...read more